institute-logo

Chitkara University Pharm. D - Fees, Eligibility, Seats and Admission 2024

LocationPatiala (Punjab)
GalleryGallery
Image
play

Chitkara University Patiala Pharm. D Fees

The fee for Pharm. D at Chitkara University Patiala is 234000 INR. Pharm. D admission 2024 at Chitkara University Patiala will be based on CBSE 12th.

DurationFees
Year 139000 INR
Year 239000 INR
Year 339000 INR
Year 439000 INR
Year 539000 INR
Year 639000 INR
Total Fees234000 INR
Show Less

Chitkara University Patiala Pharm. D Fees and Course Details

Course namePharm. D
Duration6 Years
Course levelUG
Mode of StudyRegular
Total Fees234000 INR
Show Less

Chitkara University Patiala Pharm. D Eligibility Criteria

The eligibility criteria for Pharm.D. (Doctor of Pharmacy) degree at Chitkara University, Patiala is 10+2 with Physics, Chemistry, and Biology/Mathematics with minimum 50% marks in aggregate.

Documents Required :

  • 12th mark sheet or equivalent
  • CBSE 12th mark sheet or equivalent
  • Birth certificate or any other proof of age
  • Character certificate from the last attended institution
  • Migration certificate from the last attended institution
  • Category certificate (if applicable)
  • Passport size photographs
  • Aadhaar card or any other government-issued ID proof
Show Less

Other Specializations in Pharm.D Available at Chitkara University

CourseDurationTotal Tution fees
Pharm D (Post Baccalaureate)3 Years234000 Annual

Chitkara University Reviews

D
State of the Art Infrastructure
By D V P S Pranavi | Pharm. D | 2025
March 05, 2024 01:32:00
3

Overall: Infrastructure of our department is truly remarkable, boast superior facilities that enhance the learning experience. With lightning-fast Wi-Fi, well-maintained classrooms and advanced laboratory equipment, students have access to top notch resources. The hostel amenities are also commendable, ensuring a comfortable stay for residents. While the quality of food and medical facilities is average, the canteen offers delectable meals, and sports facilities are exceptional.

Show Morereport Report